Pediatric Neurology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
Pediatric Neurology Unit, Department of Pediatrics, Complejo Hospitalario de Navarra, Navarrabiomed, Pamplona, Spain.
Parkinsonism Relat Disord. 2019 Apr;61:179-186. doi: 10.1016/j.parkreldis.2018.10.013. Epub 2018 Oct 13.
PLA2G6-associated neurodegeneration (PLAN) comprises a continuum of three phenotypes with overlapping clinical and radiologic features.
Observational clinical study in a cohort of infantile and childhood onset PLAN patients and genetic analysis of the PLA2G6 gene. We analysed chronological evolution in terms of age at onset and disease course through a 66-item questionnaire. We performed qualitative and quantitative assessment of MRI abnormalities and searched for clinical and radiological phenotype and genotype correlations.
Sixteen PLAN patients (mean age: 10.2 years, range 3-33) were evaluated, with a median onset (years) of signs/symptoms as follows: neurological regression (1.5), oculomotor abnormalities (1.5), hypotonia (1.8), gait loss (2.2), pyramidal signs (3.0), axonal neuropathy (3.0), dysphagia (4.0), optic atrophy (4.0), psychiatric symptoms (4.0), seizures (5.9), joint contractures (6.0), dystonia (8.0), bladder dysfunction (13.0) and parkinsonism (15.0). MRI assessment identified cerebellar atrophy (19/19), brain iron deposition (10/19), clava hypertrophy (8/19) and T2/FLAIR hyperintensity of the cerebellar cortex (6/19). The mid-sagittal vermis relative diameter (MVRD) correlated with age at onset of clinical variants, meaning that the earlier the onset, the more severe the cerebellar atrophy. All patients harboured missense, nonsense and frameshift mutations in PLA2G6, including four novel variants.
Cerebellar atrophy was a universal radiological sign in infantile and childhood onset PLAN, and correlated with the severity of the phenotype. Iron accumulation within the globus pallidum and substantia nigra was also a common and strikingly uniform feature regardless of the phenotype.
PLA2G6 相关神经退行性疾病(PLAN)包括三种表型的连续体,具有重叠的临床和影像学特征。
对婴儿和儿童期发病的 PLAN 患者队列进行观察性临床研究,并对 PLA2G6 基因进行基因分析。我们通过 66 项问卷分析了发病年龄和疾病进程的时间演变。我们对 MRI 异常进行了定性和定量评估,并寻找了临床和影像学表型与基因型的相关性。
评估了 16 名 PLAN 患者(平均年龄:10.2 岁,范围 3-33 岁),以下是出现症状/体征的中位发病年龄:神经退行性改变(1.5 岁)、眼球运动异常(1.5 岁)、肌张力低下(1.8 岁)、步态丧失(2.2 岁)、锥体束征(3.0 岁)、轴索性神经病(3.0 岁)、吞咽困难(4.0 岁)、视神经萎缩(4.0 岁)、精神症状(4.0 岁)、癫痫发作(5.9 岁)、关节挛缩(6.0 岁)、肌张力障碍(8.0 岁)、膀胱功能障碍(13.0 岁)和帕金森病(15.0 岁)。MRI 评估发现小脑萎缩(19/19)、脑铁沉积(10/19)、克拉瓦肥大(8/19)和小脑皮质 T2/FLAIR 高信号(6/19)。中矢状位蚓部相对直径(MVRD)与临床变异的发病年龄相关,即发病越早,小脑萎缩越严重。所有患者在 PLA2G6 中均携带错义、无义和移码突变,包括 4 种新的变异。
婴儿和儿童期发病的 PLAN 普遍存在小脑萎缩的影像学征象,且与表型严重程度相关。苍白球和黑质内铁沉积也是一种常见且非常一致的特征,与表型无关。